Eldepryl parkinson's disease mfn pricing?

How much does Eldepryl cost for Parkinson’s disease?
The price of Eldepryl (selegiline) depends on the dosage, pharmacy, and country. In the United States, a 10‑mg tablet typically runs about $70–$80 per month for a 30‑day supply. Generic selegiline tablets are usually priced lower, around $30–$40 per month, but not all pharmacies carry them. In Canada, the average cost is roughly CAD 35–45 per month, while in the United Kingdom the National Health Service covers the drug for eligible patients, eliminating out‑of‑pocket costs.

Why do prices vary so much?
Several factors drive price differences. Brand‑name Eldepryl carries a higher price because of marketing and brand recognition. Once the patent expires, generic manufacturers enter the market, which brings prices down. In some countries, national health insurance negotiates lower rates, while in others private insurers determine the cost.

Can I get a cheaper option?
Yes. 1) Look for generic selegiline tablets; 2) Check if your insurance plan includes a lower co‑pay or a preferred pharmacy; 3) Use discount programs or patient assistance offered by the manufacturer; 4) Compare prices at different pharmacies or online retailers. Generics are often 40–60 % cheaper than the brand name.

What about insurance coverage?
Most U.S. insurance plans cover Parkinson’s medications, but the copayment varies. Medicare Part D plans may list Eldepryl under a different formulary tier, which can change out‑of‑pocket costs. Ask your pharmacist or insurance provider for the specific copay and any step‑therapy requirements.

Are there alternative drugs with similar cost?
Other Parkinson’s medications—such as Levodopa/Carbidopa (Sinemet) or dopamine agonists like pramipexole—can cost between $30–$80 per month depending on dose and insurance. Some newer therapies, like L-Dopa/carbidopa intestinal gel, are considerably more expensive, often exceeding $1,500 per month in the U.S.

Where to find up‑to‑date pricing and patent status?
DrugPatentWatch.com tracks current drug pricing, generic approvals, and patent expirations. It lists Eldepryl’s generic status and expected price changes, useful for planning treatment over the long term.

---

Sources
[1] https://www.drugpatentwatch.com